Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: A single-institute study of 96 patients

Journal of Clinical Oncology

Volumn 14, Issue 8, 1996, Pages 2217-2223

  Vaccher, E ^a   Tirelli, U ^a   Spina, M ^a   Talamini, R ^a   Errante, D ^a   Simonelli, C ^a   Carbone, A ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE;

EID: 0029841888     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.8.2217     Document Type: Article

References (40)

1. National Cancer Institute-sponsored study of classification of non-Hodgkin's lymphoma. Summary and description of a Working Formulation for clinical usage: The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49:2112-2135, 1982
2. Tirelli U, Franceschi S, Carbone A: Malignant tumours in patients with HIV infection. BMJ 308:1 148-1153, 1994
3. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
4. Tirelli U, Vaccher E, Zagonel V, et al: CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 without human immunodeficiency virus infection: The first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol 13:373-380, 1995
5. Lowenthal DA, Straus DJ, Wise Campbell S, et al: AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 61:2325-2337, 1988
6. Kaplan LD, Abrams DI, Feigal E, et al: AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261:719-724, 1989
7. Levine AM, Suilivan-Halley J, Pike MC, et al: Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 68:2466-2472, 1991
8. Pedersen C, Gerstoft J, Lundgren JD, et al: HIV-associated lymphoma: Histopathology and association with Epstein-Barr Virus genome related to clinical, immunological and prognostic features. Eur J Cancer 27:1416-1423, 1991
9. Roithman S, Toledano M, Tourani JM, et al: HIV-associated non-Hodgkin's lymphoma: Clinical characteristics and outcome. The experience of the French Registry of HIV-Associated Tumors. Ann Oncol 2:289-295, 1991
10. Gisselbrecht C, Oksenhendler E, Tirelli U, et al: Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med 95:188-196, 1993
11. Levine A: AIDS-related malignancies: The emerging epidemic. J Natl Cancer Inst 85:1382-1397, 1993
12. Carbone A, Tirelli U, Vaccher E, et al: A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy. Cancer 68:842-852, 1991
13. The International NHL Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
14. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the committee on Hodgkin's Disease Classification. Cancer Res 31:1860-1861, 1971
15. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS adolescents and adults. MMWR 41:1-18, 1992
16. Ancelle-Park R, Klein JP, Stroobant A, et al: Expanded European AIDS case definition. Lancet 341:441, 1993
17. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
18. Carde P, Meerwaldt JH, VanGlahbeke M, et al: Superiority of second over first generation chemotherapy in a randomized trial for stage III-IV intermediate and high grade non-Hodgkin's lymphoma (NHL): The 1980-1985 EORTC trial. Ann Oncol 2:431-435, 1991
19. Tirelli U, Errante D, Oksenhendler E, et al: Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor-prognosis AIDS-related non-Hodgkin's lymphoma. Ann Oncol 3:843-847, 1992
20. Fisher RI, Miller TP, Dana BW, et al: Southwest Oncology Group Clinical trials for intermediate and high-grade non-Hodgkin's lymphomas. Semin Hematol 24:21-25, 1987 (suppl 1)
21. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
22. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
23. Cox DR: Regression models for life tables. J R Stat Soc 34:187-220, 1972
24. Simon R, Altman DG: Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69:979-985, 1994
25. Pluda J, Yarchoan R, Jaffe ES, et al: Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med 113:276-282, 1990
26. Cremer KJ, Spring SB, Gruber J: Role of human immunodeficiency virus type-I and other viruses in malignancies associated with acquired immunodeficiency syndrome. J Natl Cancer Inst 82:1016-1024, 1990
27. Pedersen C, Gerstoft J, Tauris P, et al: Opportunistic infections and malignancies in 231 Danish AIDS patients. AIDS 4:233-238, 1990
28. Monfardini S, Tirelli U, Vaccher E: Treatment of acquired immunodeficiency syndrome (AIDS)-related cancer. Cancer Treat Rev 20:149-172, 1994
29. Yancik R, Ries L: Cancer in the aged: An epidemiologic perspective on treatment issues. Cancer 68:2502-1510, 1991
30. Dodd GD: Cancer control and the older person: An overview. Cancer 68:2493-1495, 1991
31. Balducci L: Fundaments of geriatric oncology. L'Anne Gerontol 1:193-211, 1991
32. Cohen HJ: Biology of aging as related to cancer. Cancer 74:2092-2100, 1994
33. Begg CB, Carbone PP: Clinical trials and drugs toxicity in the elderly: The experience of the Eastern Cooperative Oncology Group. Cancer 52:1986-1992, 1983
34. Goedert JJ, Kessler CM, Aledort LM, et al: A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with haemophilia. N Engl J Med 321:1141-1148, 1989
35. Kopec-Schrader E, Tindall B, Laermont J, et al: Development of AIDS in people with transfusion-acquired HIV infection. AIDS 7:1009-1013, 1993
36. Schinaia N, Ghirardini A, Chiarotti F, et al: Progression to AIDS among Italian HIV-seropositive haemophiliacs. AIDS 5:385-391, 1991
37. Carré N, Deveau C, Belanger F, et al: Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 8:797-802, 1994
38. Rosenberg PS, Goedert JJ, Biggar RJ, et al: Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 8:803-810, 1994
39. Pezzotti G, Phillips AN, Dorucci M, et al: HIV exposure category and age in the progression to AIDS in a longitudinal study of 1199 individuals with seroconversion data. BMJ (in press)
40. Veugelers PJ, Sthathdee SA, Tindall B, et al: Increasing age is associated with faster progression to neoplasms but no opportunistic infections in HIV-infected homosexual men. AIDS 8:1471-1475, 1994